Ewing Sarcoma — Trials

Ewing Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 76
Recruiting: 41
Ph III recruiting: 1
Growth YoY: —
Industry share: 17%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (30)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01795430	Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma	withdrawn	N/A	0	City of Hope Medical CenterOTHER	1	Jan 9, 2015	clinicaltrials
NCT01492569	Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting	withdrawn	N/A	0	Stanford UniversityOTHER	1	Jun 12, 2013	clinicaltrials